Hyeong-Seok Lim

ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma

Ivana Yen, Jeeyun Lee, Yong Sang Hong et al. · Nature · 2021 · 135 citations · Full text

Medicine, Oncology, Pharmacology +14

Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: A single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers

Jinah Jung, Sang-Min Choi, Sang‐Heon Cho et al. · Clinical Therapeutics · 2010 · 70 citations

Medicine, Pharmacokinetics, Pharmacology +8

HAPLOTYPE STRUCTURE AND ALLELE FREQUENCIES OF CYP2B6 IN A KOREAN POPULATION

Joo‐Youn Cho, Hyeong-Seok Lim, Jae‐Yong Chung et al. · Drug Metabolism and Disposition · 2004 · 50 citations

Medicine, Genetics, Molecular Genetics +17

Effects of Pregnane X Receptor (NR1I2) and CYP2B6 Genetic Polymorphisms on the Induction of Bupropion Hydroxylation by Rifampin

Jae‐Yong Chung, Joo‐Youn Cho, Hyeong-Seok Lim et al. · Drug Metabolism and Disposition · 2010 · 34 citations · Full text

Veterinary Medicine, Pharmacokinetics, Pharmacology +14

A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival

Young‐Woo Kim, Mi Jung Kim, Keun Won Ryu et al. · Gastric Cancer · 2015 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +15